US 8710026
MiR 204, miR 211, their anti-miRs, and therapeutic uses of same
granted A61KA61K31/7105A61P
Quick answer
US patent 8710026 (MiR 204, miR 211, their anti-miRs, and therapeutic uses of same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/7105, A61P, A61P27/02, A61P27/10